FDA Adverse Event Injury Summary report: N

VERCISE GENUS?

MDR report key: 23998231 · Received January 7, 2026

Report

Report Number
3006630150-2026-00168
Event Type
Injury
Date Received
January 7, 2026
Date of Event
March 1, 2025
Report Date
March 26, 2026
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Product Code
MHY
UDI-DI
08714729985044
PMA / PMN Number
P150031
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE DB-1216, SERIAL NUMBER: (B)(6), WAS NOT RETURNED FOR ANALYSIS; THEREFORE, A TECHNICAL ANALYSIS COULD NOT BE PERFORMED. A LABELING REVIEW DID NOT REVEAL ANY ANOMALIES AS IT STATES THAT INFECTION, IMPLANTED DEVICE COMPONENTS (STIMULATOR, LEAD, OR LEAD EXTENSION) MAY MOVE FROM ORIGINAL IMPLANTED LOCATION OR WEAR THROUGH THE SKIN, WHICH MAY LEAD TO THE NEED FOR ADDITIONAL SURGERY AND IMPLANT SITE COMPLICATIONS SUCH AS PAIN, POOR HEALING, REDNESS, WARMTH, SWELLING OR WOUND REOPENING ARE A KNOWN RISKS WITH THE USE OF DEEP BRAIN STIMULATION (DBS). BASED ON A THOROUGH REVIEW OF THE REPORTED COMPLAINT, BOSTON SCIENTIFIC HAS ASSIGNED AN INVESTIGATION CONCLUSION CODE OF: KNOWN INHERENT RISK OF DEVICE. THE DEVICE DB-3128-55B, SERIAL NUMBER: (B)(6), WAS NOT RETURNED FOR ANALYSIS; THEREFORE, A TECHNICAL ANALYSIS COULD NOT BE PERFORMED. A LABELING REVIEW DID NOT REVEAL ANY ANOMALIES AS IT STATES THAT INFECTION, IMPLANTED DEVICE COMPONENTS (STIMULATOR, LEAD, OR LEAD EXTENSION) MAY MOVE FROM ORIGINAL IMPLANTED LOCATION OR WEAR THROUGH THE SKIN, WHICH MAY LEAD TO THE NEED FOR ADDITIONAL SURGERY AND IMPLANT SITE COMPLICATIONS SUCH AS PAIN, POOR HEALING, REDNESS, WARMTH, SWELLING OR WOUND REOPENING ARE A KNOWN RISKS WITH THE USE OF DEEP BRAIN STIMULATION (DBS). BASED ON A THOROUGH REVIEW OF THE REPORTED COMPLAINT, BOSTON SCIENTIFIC HAS ASSIGNED AN INVESTIGATION CONCLUSION CODE OF: KNOWN INHERENT RISK OF DEVICE. B3: ESTIMATED BASED ON GFE RESPONSE FROM SALES REPRESENTATIVE. D2B: ADDITIONAL PRO CODE SELECTION THAT APPLIES TO THE INDICATION OF THIS DEVICE - < NHL, PJS>. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-EXTENSION, UPN: M365DB312855B0, MODEL: DB-3128-55B, SERIAL: (B)(6), BATCH: 5000416, UDI: (B)(4).

Additional Manufacturer Narrative · 0

B3: ESTIMATED BASED ON GFE RESPONSE FROM SALES REPRESENTATIVE. D2B: ADDITIONAL PRO CODE SELECTION THAT APPLIES TO THE INDICATION OF THIS DEVICE - NHL, PJS. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-EXTENSION. UPN: M365DB312855B0. MODEL: DB-3128-55B. SERIAL: (B)(6). BATCH: 5000416. UDI: (B)(4).

Additional Manufacturer Narrative · 0

B3: ESTIMATED BASED ON GFE RESPONSE FROM SALES REPRESENTATIVE. D2B: ADDITIONAL PRO CODE SELECTION THAT APPLIES TO THE INDICATION OF THIS DEVICE - < NHL, PJS>. ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENTS INVOLVED IN THE EVENT: PRODUCT FAMILY: DBS-EXTENSION. UPN: M365DB312855B0. MODEL: DB-3128-55B. SERIAL: (B)(6). BATCH: 5000416. UDI: (B)(4).

Description of Event or Problem · 0

IT WAS REPORTED THAT THE SPINAL CORD STIMULATION (SCS) PATIENT UNDERWENT A PROCEDURE WHEREIN THE IMPLANTABLE PULSE GENERATOR (IPG) AND LEAD EXTENSION WERE EXPLANTED DUE TO AN INFECTION. THE DEVICES WERE RETAINED DUE TO FACILITY POLICY AND WILL NOT BE RETURNED FOR ANALYSIS. POSTOPERATIVELY, THE PATIENT WAS FULLY RECOVERED. ADDITIONAL INFORMATION WAS RECEIVED INDICATING THAT THE INFECTION WAS LOCATED AT THE CHEST POCKET PARIETAL INCISION, WHERE THE EXTENSION HAD BEEN PLACED. ACCORDING TO THE PHYSICIAN ASSESSMENT, THE INFECTION WAS NOT CONSIDERED DEVICE RELATED, AND NO PROCEDURAL FACTORS WERE BELIEVED TO HAVE CONTRIBUTED. THE CAUSE OF THE INFECTION REMAINED UNDETERMINED. THE PATIENT WAS PLACED ON ANTIBIOTIC THERAPY, AND CULTURES WERE OBTAINED; HOWEVER, THE RESULTS WERE NOT AVAILABLE. THE SYMPTOMS OF THE INFECTION WERE REDNESS, SWELLING, DISCHARGE AND WOUND DEHISCENCE.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE SPINAL CORD STIMULATION (SCS) PATIENT UNDERWENT A PROCEDURE WHEREIN THE IMPLANTABLE PULSE GENERATOR (IPG) AND LEAD EXTENSION WERE EXPLANTED DUE TO AN INFECTION. THE DEVICES WERE RETAINED DUE TO FACILITY POLICY AND WILL NOT BE RETURNED FOR ANALYSIS. POSTOPERATIVELY, THE PATIENT WAS FULLY RECOVERED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE SPINAL CORD STIMULATION (SCS) PATIENT UNDERWENT A PROCEDURE WHEREIN THE IMPLANTABLE PULSE GENERATOR (IPG) AND LEAD EXTENSION WERE EXPLANTED DUE TO AN INFECTION. THE DEVICES WERE RETAINED DUE TO FACILITY POLICY AND WILL NOT BE RETURNED FOR ANALYSIS. POSTOPERATIVELY, THE PATIENT WAS FULLY RECOVERED. ADDITIONAL INFORMATION WAS RECEIVED INDICATING THAT THE INFECTION WAS LOCATED AT THE CHEST POCKET PARIETAL INCISION, WHERE THE EXTENSION HAD BEEN PLACED. ACCORDING TO THE PHYSICIAN ASSESSMENT, THE INFECTION WAS NOT CONSIDERED DEVICE RELATED, AND NO PROCEDURAL FACTORS WERE BELIEVED TO HAVE CONTRIBUTED. THE CAUSE OF THE INFECTION REMAINED UNDETERMINED. THE PATIENT WAS PLACED ON ANTIBIOTIC THERAPY, AND CULTURES WERE OBTAINED; HOWEVER, THE RESULTS WERE NOT AVAILABLE. THE SYMPTOMS OF THE INFECTION WERE REDNESS, SWELLING, DISCHARGE AND WOUND DEHISCENCE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
60871 VERCISE GENUS? STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR MHY BOSTON SCIENTIFIC NEUROMODULATION CORPORATION DB-1216 591698 08714729985044

Patients

Seq Age Sex Outcome Treatment
1 73 YR Female Required Intervention